Kempen Capital Management N.V. Merck & Co., Inc. Transaction History
Kempen Capital Management N.V.
- $9.59 Billion
- Q3 2024
A detailed history of Kempen Capital Management N.V. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Kempen Capital Management N.V. holds 1,800,550 shares of MRK stock, worth $179 Million. This represents 2.13% of its overall portfolio holdings.
Number of Shares
1,800,550
Previous 1,800,323
0.01%
Holding current value
$179 Million
Previous $223 Million
8.26%
% of portfolio
2.13%
Previous 2.53%
Shares
28 transactions
Others Institutions Holding MRK
# of Institutions
3,827Shares Held
1.87BCall Options Held
15.6MPut Options Held
13.7M-
Vanguard Group Inc Valley Forge, PA250MShares$24.8 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$20.6 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$11.8 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$7.54 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.88 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $252B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...